GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » Equity-to-Asset

Actavia Life Sciences (Actavia Life Sciences) Equity-to-Asset : -80.92 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Actavia Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-2.10 Mil. Actavia Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was $0.03 Mil.

The historical rank and industry rank for Actavia Life Sciences's Equity-to-Asset or its related term are showing as below:

RASP' s Equity-to-Asset Range Over the Past 10 Years
Min: -942.67   Med: -0.18   Max: 1
Current: -80.92

During the past 11 years, the highest Equity to Asset Ratio of Actavia Life Sciences was 1.00. The lowest was -942.67. And the median was -0.18.

RASP's Equity-to-Asset is ranked worse than
99.62% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs RASP: -80.92

Actavia Life Sciences Equity-to-Asset Historical Data

The historical data trend for Actavia Life Sciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actavia Life Sciences Equity-to-Asset Chart

Actavia Life Sciences Annual Data
Trend Jun14 Jun15 Jun16 Mar17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 -81.06 -61.20 -19.87 -20.38

Actavia Life Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.67 -35.96 -53.38 -20.38 -80.92

Competitive Comparison of Actavia Life Sciences's Equity-to-Asset

For the Biotechnology subindustry, Actavia Life Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actavia Life Sciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actavia Life Sciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Actavia Life Sciences's Equity-to-Asset falls into.



Actavia Life Sciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Actavia Life Sciences's Equity to Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Equity to Asset (A: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-1.956/0.096
=

Actavia Life Sciences's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-2.104/0.026
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actavia Life Sciences  (OTCPK:RASP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Actavia Life Sciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Actavia Life Sciences (Actavia Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170
Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines